ICU — SeaStar Medical Holding Share News
0.000.00%
Last trade - 00:00- $13.48m
- $6.66m
- $1.23m
SeaStar Medical Holding Corp reports results for the quarter ended June 30 - Earnings Summary
SeaStar Medical Q2 revenue jumps 82% on QUELIMMUNE demand
Brief: SeaStar Medical Q2 EPS USD -0.91
SeaStar Medical Holding Corp expected to post a loss of 97 cents a share - Earnings Preview
SeaStar Medical Holding Corp expected to post a loss of 97 cents a share - Earnings Preview
SeaStar Medical Q1 revenue rises on QUELIMMUNE growth
Brief: SeaStar Medical Q1 EPS USD -0.9
Brief: Seastar Medical Holding Corp - Prospectus Relates To Resale, From Time To Time, Of Up To 2 Million Shares Of Our Common Stock By Selling Stockholder
SeaStar Medical's Q4 revenue rises, net loss narrows
Brief: Seastar Medical Announces Completion Of FDA Enrollment Requirement For Save Surveillance Registry Evaluating Quelimmune Safety For Pediatric Aki
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
Brief: Seastar Medical Announces FDA Approval Of Reduction In Mandatory Enrollment
Brief: Seastar Medical Announces Appointment Of Michael Messinger As CFO
SeaStar Medical Q3 net loss narrows
Brief: SeaStar Medical Q3 EPS USD -0.13